Pedro P. López‐Casas

3.0k total citations
52 papers, 1.8k citations indexed

About

Pedro P. López‐Casas is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Pedro P. López‐Casas has authored 52 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 25 papers in Molecular Biology and 22 papers in Cancer Research. Recurrent topics in Pedro P. López‐Casas's work include Pancreatic and Hepatic Oncology Research (16 papers), Cancer Genomics and Diagnostics (14 papers) and Cancer Cells and Metastasis (5 papers). Pedro P. López‐Casas is often cited by papers focused on Pancreatic and Hepatic Oncology Research (16 papers), Cancer Genomics and Diagnostics (14 papers) and Cancer Cells and Metastasis (5 papers). Pedro P. López‐Casas collaborates with scholars based in Spain, United States and Italy. Pedro P. López‐Casas's co-authors include Manuel Hidalgo, Mónica Musteanu, Fernando López‐Ríos, Jesús del Mazo, Camino Menéndez, Manuel Muñoz, Emilio González-González, Carlos Plaza, Mariano Barbacid and Carmen Guerra and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Cell.

In The Last Decade

Pedro P. López‐Casas

49 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pedro P. López‐Casas Spain	25	978	702	540	340	317	52	1.8k
Sharrell Lee United States	6	994 1.0×	1.1k 1.6×	597 1.1×	201 0.6×	239 0.8×	9	1.8k
Sanaz Memarzadeh United States	23	918 0.9×	1.1k 1.5×	424 0.8×	439 1.3×	345 1.1×	60	2.3k
María Virtudes Céspedes Spain	7	1.0k 1.1×	872 1.2×	410 0.8×	180 0.5×	240 0.8×	9	1.7k
Eiji Sugihara Japan	26	810 0.8×	1.2k 1.7×	546 1.0×	246 0.7×	411 1.3×	67	2.3k
Wiam Bshara United States	25	746 0.8×	811 1.2×	402 0.7×	328 1.0×	314 1.0×	73	1.7k
Ana Cerezo Spain	13	841 0.9×	1.1k 1.5×	358 0.7×	253 0.7×	170 0.5×	16	2.0k
Pinaki Bose Canada	20	728 0.7×	1.0k 1.5×	357 0.7×	227 0.7×	354 1.1×	42	1.8k
Ying Ma China	20	620 0.6×	741 1.1×	310 0.6×	243 0.7×	480 1.5×	81	1.7k
Li-Chuan Chan Taiwan	17	1.2k 1.2×	965 1.4×	406 0.8×	425 1.3×	779 2.5×	27	2.1k
Ernst J.A. Steller Netherlands	15	741 0.8×	717 1.0×	424 0.8×	151 0.4×	241 0.8×	20	1.5k

Countries citing papers authored by Pedro P. López‐Casas

Since Specialization

Citations

This map shows the geographic impact of Pedro P. López‐Casas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro P. López‐Casas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro P. López‐Casas more than expected).

Fields of papers citing papers by Pedro P. López‐Casas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro P. López‐Casas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro P. López‐Casas. The network helps show where Pedro P. López‐Casas may publish in the future.

Co-authorship network of co-authors of Pedro P. López‐Casas

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro P. López‐Casas. A scholar is included among the top collaborators of Pedro P. López‐Casas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro P. López‐Casas. Pedro P. López‐Casas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiménez‐Vacas, Juan M., Enrique Gómez‐Gómez, Antonio C. Fuentes-Fayos, et al.. (2022). Tumor suppressor role of RBM22 in prostate cancer acting as a dual-factor regulating alternative splicing and transcription of key oncogenic genes. Translational research. 253. 68–79. 4 indexed citations

Perales-Patón, Javier, Bruno Bockorny, Ana Dopazo, et al.. (2020). Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells. Molecular Cancer Therapeutics. 19(8). 1751–1760. 35 indexed citations

Fabre, Myriam, Cristina Suárez Ferrer, Bruno Bockorny, et al.. (2020). OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models. Clinical Cancer Research. 26(13). 3420–3430. 74 indexed citations

Kalbasi, Anusha, Kevin Hakimi, Sarah Kremer, et al.. (2020). Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma. Science Translational Medicine. 12(565). 79 indexed citations

Aznar, M. Ángela, Lourdes Planelles, Carmen Molina, et al.. (2019). Immunotherapeutic effects of intratumoral nanoplexed poly I:C. Journal for ImmunoTherapy of Cancer. 7(1). 116–116. 103 indexed citations

Malvicini, Mariana, Ana Gutiérrez‐Moraga, Lorena Salazar, et al.. (2018). A Tricin Derivative from Deschampsia antarctica Desv. Inhibits Colorectal Carcinoma Growth and Liver Metastasis through the Induction of a Specific Immune Response. Molecular Cancer Therapeutics. 17(5). 966–976. 23 indexed citations

Gilles, Maud-Emmanuelle, Liangliang Hao, Ling Huang, et al.. (2018). Personalized RNA Medicine for Pancreatic Cancer. Clinical Cancer Research. 24(7). 1734–1747. 54 indexed citations

Piñeiro-Yáñez, Elena, Miguel Reboiro‐Jato, Gonzalo Goméz-López, et al.. (2018). PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data. Genome Medicine. 10(1). 41–41. 60 indexed citations

Márquez‐Rodas, Iván, Federico Longo, María E. Rodríguez-Ruiz, et al.. (2018). Intratumoral BO-112, a double-stranded RNA (dsRNA), alone and in combination with systemic anti-PD-1 in solid tumors. Annals of Oncology. 29. viii732–viii732. 7 indexed citations

10.

Novoa-Carballal, Ramón, Anxo Vidal, Marta Alonso‐Nocelo, et al.. (2018). A multifunctional drug nanocarrier for efficient anticancer therapy. Journal of Controlled Release. 294. 154–164. 29 indexed citations

11.

Perales-Patón, Javier, Elena Piñeiro-Yáñez, Héctor Tejero, et al.. (2017). Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective. Public Health Genomics. 20(2). 81–91. 6 indexed citations

12.

Hidalgo, Manuel, Carlos Plaza, Mónica Musteanu, et al.. (2015). SPARC Expression Did Not Predict Efficacy of nab -Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial. Clinical Cancer Research. 21(21). 4811–4818. 102 indexed citations

13.

Azaro, Analía, Jordi Rodón, Antonio Calles, et al.. (2015). A first-in-human phase I trial of LY2780301, a dual p70 S6 kinase and Akt Inhibitor, in patients with advanced or metastatic cancer. Investigational New Drugs. 33(3). 710–719. 25 indexed citations

14.

Garralda, Elena, Keren Paz, Pedro P. López‐Casas, et al.. (2014). Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment. Clinical Cancer Research. 20(9). 2476–2484. 107 indexed citations

15.

Morelli, Maria Pia, Emiliano Calvo, Michael J. Wick, et al.. (2011). Prioritizing Phase I Treatment Options Through Preclinical Testing on Personalized Tumorgraft. Journal of Clinical Oncology. 30(4). e45–e48. 61 indexed citations

16.

Bermúdez, Valmore, et al.. (2009). Iatrogenic equine metabolic syndrome in thoroughbred horses. Redalyc (Universidad Autónoma del Estado de México). 28(2). 77–81.

17.

Martín‐Santamaría, Sonsoles, Sonia de Pascual‐Teresa, Sandra Gordon, et al.. (2008). New scaffolds for the design of selective estrogen receptor modulators. Organic & Biomolecular Chemistry. 6(19). 3486–3486. 24 indexed citations

18.

Paz, Maria F., Pedro P. López‐Casas, & Jesús del Mazo. (2007). Changes in Vinexin Expression Patterns in the Mouse Testis Induced by Developmental Exposure to 17Beta-Estradiol1. Biology of Reproduction. 77(4). 605–613. 10 indexed citations

19.

López‐Casas, Pedro P., Luis A. López‐Fernández, Mario Párraga, Dora B. Krimer, & Jesús del Mazo. (2003). Developmental regulation of expression of Ran/M1 and Ran/M2 isoforms of Ran-GTPase in mouse testis. The International Journal of Developmental Biology. 47(4). 307–310. 10 indexed citations

20.

López‐Casas, Pedro P., Juán F. Santarén, María Fernanda Ruiz, P. Esponda, & Lucas Sánchez. (2001). The Drosophila melanogaster X-Linked mfs(1)6E Locus Is Required for Production of Normal Seminal Fluid by the Male Accessory Glands. Experimental Cell Research. 267(1). 1–12. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact